🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study dynamically monitored the prognosis of stage I-IV colorectal can...
Status
Active Not Recruiting
Location
Cancer hospital Chinese academy of medical sciences
Start Date
2022-06-20
Trial ID
NCT05444491
The goal of this observational study is to explore whether ctDNA-MRD dynami...
Status
Not Yet Recruiting
Location
Department of Thoracic Surgery, Second Xiangya Hospital of Central South University, China
Start Date
2023-04
Trial ID
NCT05822284
Treatments Being Tested
The presence of minimal residual disease (MRD) is an important prognostic f...
Status
Unknown
Location
InsituteHBDH
Start Date
2023-05-01
Trial ID
NCT06302699
The goal of this study is to evaluate sustained MRD negativity for one year...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-06-12
Trial ID
NCT06409702
Treatments Being Tested
Adding immune checkpoint inhibitors or molecularly targeted drugs as adjuva...
Status
Not Yet Recruiting
Location
National Cancer Center Hospital
Start Date
2025-03-01
Trial ID
NCT06854939
The goal of this clinical trial is to learn the efficacy and safety of zanu...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-01-01
Trial ID
NCT06959732
Treatments Being Tested
This phase II trial studies how well pirtobrutinib and venetoclax work in t...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Start Date
2023-01-31
Trial ID
NCT05677919
Anti-HER2 therapy, such as trastuzumab and pertuzumab, has significantly im...
Status
Active Not Recruiting
Location
Natera
Start Date
2024-04-01
Trial ID
NCT06663787
Treatments Being Tested
The purpose of this study is to 1) determine whether it is feasible to meas...
Status
Recruiting
Location
Columbia University
Start Date
2024-12-11
Trial ID
NCT06693830
Based on the unique patented MONOD and Methyl Titan methylation sequencing ...
Status
Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2023-10-25
Trial ID
NCT05965024